XB-ART-46409
Mol Cell
2012 Sep 28;476:827-38. doi: 10.1016/j.molcel.2012.09.008.
Show Gene links
Show Anatomy links
Molecular roadblocks for cellular reprogramming.
Vierbuchen T
,
Wernig M
.
???displayArticle.abstract???
During development, diverse cellular identities are established and maintained in the embryo. Although remarkably robust in vivo, cellular identities can be manipulated using experimental techniques. Lineage reprogramming is an emerging field at the intersection of developmental and stem cell biology in which a somatic cell is stably reprogrammed into a distinct cell type by forced expression of lineage-determining factors. Lineage reprogramming enables the direct conversion of readily available cells from patients (such as skin fibroblasts) into disease-relevant cell types (such as neurons and cardiomyocytes) or into induced pluripotent stem cells. Although remarkable progress has been made in developing novel reprogramming methods, the efficiency and fidelity of reprogramming need to be improved in order increase the experimental and translational utility of reprogrammed cells. Studying the mechanisms that prevent successful reprogramming should allow for improvements in reprogramming methods, which could have significant implications for regenerative medicine and the study of human disease. Furthermore, lineage reprogramming has the potential to become a powerful system for dissecting the mechanisms that underlie cell fate establishment and terminal differentiation processes. In this review, we will discuss how transcription factors interface with the genome and induce changes in cellular identity in the context of development and reprogramming.
???displayArticle.pubmedLink??? 23020854
???displayArticle.pmcLink??? PMC3809030
???displayArticle.link??? Mol Cell
???displayArticle.grants??? [+]
AG010770-18A1 NIA NIH HHS , R01MH092931 NIMH NIH HHS, RC4 NS073015-01 NINDS NIH HHS , RC4 NS073015 NINDS NIH HHS , P01 AG010770 NIA NIH HHS , R01 MH092931 NIMH NIH HHS
GO keywords: cell fate specification [+]
References [+] :
Almer,
Nuclease hypersensitive regions with adjacent positioned nucleosomes mark the gene boundaries of the PHO5/PHO3 locus in yeast.
1986, Pubmed
Almer, Nuclease hypersensitive regions with adjacent positioned nucleosomes mark the gene boundaries of the PHO5/PHO3 locus in yeast. 1986, Pubmed
Ambasudhan, Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions. 2011, Pubmed
Anokye-Danso, Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. 2011, Pubmed
Aoki, Genetic ablation of Rest leads to in vitro-specific derepression of neuronal genes during neurogenesis. 2012, Pubmed
Aziz, Regulating a master regulator: establishing tissue-specific gene expression in skeletal muscle. 2010, Pubmed
Beisel, Silencing chromatin: comparing modes and mechanisms. 2011, Pubmed
Bell, Determinants and dynamics of genome accessibility. 2011, Pubmed
Bergstrom, Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. 2002, Pubmed
Berninger, Functional properties of neurons derived from in vitro reprogrammed postnatal astroglia. 2007, Pubmed
Bertrand, Proneural genes and the specification of neural cell types. 2002, Pubmed
Bhutani, Reprogramming towards pluripotency requires AID-dependent DNA demethylation. 2010, Pubmed
Blau, Plasticity of the differentiated state. 1985, Pubmed
Blau, Cytoplasmic activation of human nuclear genes in stable heterocaryons. 1983, Pubmed
Briggs, Transplantation of Living Nuclei From Blastula Cells into Enucleated Frogs' Eggs. 1952, Pubmed
Bussmann, A robust and highly efficient immune cell reprogramming system. 2009, Pubmed
Caiazzo, Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. 2011, Pubmed
Campbell, Sheep cloned by nuclear transfer from a cultured cell line. 1996, Pubmed
Cao, Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming. 2010, Pubmed
Carey, Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. 2011, Pubmed
Chiu, 5-Azacytidine permits gene activation in a previously noninducible cell type. 1985, Pubmed
Chong, REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons. 1995, Pubmed
Cirillo, Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. 2002, Pubmed
Cowan, Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. 2005, Pubmed
Creyghton, Histone H3K27ac separates active from poised enhancers and predicts developmental state. 2010, Pubmed
Davis, Expression of a single transfected cDNA converts fibroblasts to myoblasts. 1987, Pubmed
Di Tullio, C/EBPα bypasses cell cycle-dependency during immune cell transdifferentiation. 2012, Pubmed
Eggan, Mice cloned from olfactory sensory neurons. 2004, Pubmed
Feng, PU.1 and C/EBPalpha/beta convert fibroblasts into macrophage-like cells. 2008, Pubmed
Fong, Genetic and epigenetic determinants of neurogenesis and myogenesis. 2012, Pubmed
Foshay, Embryonic stem cells induce pluripotency in somatic cell fusion through biphasic reprogramming. 2012, Pubmed
GURDON, Sexually mature individuals of Xenopus laevis from the transplantation of single somatic nuclei. 1958, Pubmed , Xenbase
Gaetz, Evidence for a critical role of gene occlusion in cell fate restriction. 2012, Pubmed
Graf, Forcing cells to change lineages. 2009, Pubmed
Graf, Historical origins of transdifferentiation and reprogramming. 2011, Pubmed
Gurdon, From nuclear transfer to nuclear reprogramming: the reversal of cell differentiation. 2006, Pubmed , Xenbase
Halder, Induction of ectopic eyes by targeted expression of the eyeless gene in Drosophila. 1995, Pubmed
Han, Constructing and deconstructing stem cell models of neurological disease. 2011, Pubmed
Hanna, Direct cell reprogramming is a stochastic process amenable to acceleration. 2009, Pubmed
Hanna, Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. 2008, Pubmed
Hanna, Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. 2010, Pubmed
Heinrich, Directing astroglia from the cerebral cortex into subtype specific functional neurons. 2010, Pubmed
Heins, Glial cells generate neurons: the role of the transcription factor Pax6. 2002, Pubmed
Ho, Chromatin remodelling during development. 2010, Pubmed
Hochedlinger, Epigenetic reprogramming and induced pluripotency. 2009, Pubmed
Hochedlinger, Nuclear reprogramming and pluripotency. 2006, Pubmed
Hochedlinger, Monoclonal mice generated by nuclear transfer from mature B and T donor cells. 2002, Pubmed
Holmberg, Maintaining differentiated cellular identity. 2012, Pubmed
Hornstein, Canalization of development by microRNAs. 2006, Pubmed
Huang, Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. 2011, Pubmed
Huangfu, Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. 2008, Pubmed
Ieda, Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. 2010, Pubmed
John, Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. 2011, Pubmed
Kajimura, Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex. 2009, Pubmed
Kim, Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. 2011, Pubmed
Kim, Epigenetic memory in induced pluripotent stem cells. 2010, Pubmed
Koche, Reprogramming factor expression initiates widespread targeted chromatin remodeling. 2011, Pubmed
Lahn, The "occlusis" model of cell fate restriction. 2011, Pubmed
Li, Rapid spontaneous accessibility of nucleosomal DNA. 2005, Pubmed
Lujan, Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells. 2012, Pubmed
Maherali, Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. 2007, Pubmed
Marro, Direct lineage conversion of terminally differentiated hepatocytes to functional neurons. 2011, Pubmed
Meissner, Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. 2007, Pubmed
Miller, Muscle cell components dictate hepatocyte gene expression and the distribution of the Golgi apparatus in heterokaryons. 1988, Pubmed
Ming, Cellular reprogramming: recent advances in modeling neurological diseases. 2011, Pubmed
Mitsui, The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. 2003, Pubmed
Miyoshi, Reprogramming of mouse and human cells to pluripotency using mature microRNAs. 2011, Pubmed
Ng, Epigenetic memory of an active gene state depends on histone H3.3 incorporation into chromatin in the absence of transcription. 2008, Pubmed , Xenbase
Ng, Epigenetic memory of active gene transcription is inherited through somatic cell nuclear transfer. 2005, Pubmed , Xenbase
Okita, Generation of germline-competent induced pluripotent stem cells. 2007, Pubmed
Palermo, Nuclear reprogramming in heterokaryons is rapid, extensive, and bidirectional. 2009, Pubmed
Palii, Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages. 2011, Pubmed
Pang, Induction of human neuronal cells by defined transcription factors. 2011, Pubmed
Pasque, Epigenetic factors influencing resistance to nuclear reprogramming. 2011, Pubmed , Xenbase
Pereira, ESCs require PRC2 to direct the successful reprogramming of differentiated cells toward pluripotency. 2010, Pubmed
Pereira, Heterokaryon-based reprogramming of human B lymphocytes for pluripotency requires Oct4 but not Sox2. 2008, Pubmed
Pfisterer, Direct conversion of human fibroblasts to dopaminergic neurons. 2011, Pubmed
Piccolo, Using heterokaryons to understand pluripotency and reprogramming. 2011, Pubmed
Polo, Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. 2010, Pubmed
Probst, Epigenetic inheritance during the cell cycle. 2009, Pubmed
Qiang, Directed conversion of Alzheimer's disease patient skin fibroblasts into functional neurons. 2011, Pubmed
Rada-Iglesias, A unique chromatin signature uncovers early developmental enhancers in humans. 2011, Pubmed , Xenbase
Saha, Technical challenges in using human induced pluripotent stem cells to model disease. 2009, Pubmed
Schäfer, Effect of cell history on response to helix-loop-helix family of myogenic regulators. 1990, Pubmed
Sekiya, Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. 2011, Pubmed
Shen, Molecular basis of transdifferentiation of pancreas to liver. 2000, Pubmed
Silva, Capturing pluripotency. 2008, Pubmed
Son, Conversion of mouse and human fibroblasts into functional spinal motor neurons. 2011, Pubmed
Sridharan, Role of the murine reprogramming factors in the induction of pluripotency. 2009, Pubmed
Stadtfeld, Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells. 2012, Pubmed
Sun, Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. 2001, Pubmed , Xenbase
Szabo, Direct conversion of human fibroblasts to multilineage blood progenitors. 2010, Pubmed
Taberlay, Polycomb-repressed genes have permissive enhancers that initiate reprogramming. 2011, Pubmed
Tada, Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. 2001, Pubmed
Takahashi, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. 2006, Pubmed
Tapscott, The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. 2005, Pubmed
Taylor, Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. 1979, Pubmed
Vierbuchen, Direct conversion of fibroblasts to functional neurons by defined factors. 2010, Pubmed
Vierbuchen, Direct lineage conversions: unnatural but useful? 2011, Pubmed
Wakayama, Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. 1998, Pubmed
Weintraub, Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. 1989, Pubmed
Weintraub, The MyoD family and myogenesis: redundancy, networks, and thresholds. 1993, Pubmed
Wilson, Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators. 2010, Pubmed
Xie, Stepwise reprogramming of B cells into macrophages. 2004, Pubmed
Xu, A chemical approach to stem-cell biology and regenerative medicine. 2008, Pubmed
Yamanaka, Nuclear reprogramming to a pluripotent state by three approaches. 2010, Pubmed
Yoo, MicroRNA-mediated conversion of human fibroblasts to neurons. 2011, Pubmed
Yoo, MicroRNA-mediated switching of chromatin-remodelling complexes in neural development. 2009, Pubmed
Zaret, Pioneer transcription factors: establishing competence for gene expression. 2011, Pubmed
Zhou, In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. 2008, Pubmed
Zhou, Extreme makeover: converting one cell into another. 2008, Pubmed